Operating from a sprawling 12,000-square-foot facility in Riverdale, New Jersey, PDA Laboratories is a premier third-party partner for microbiology and analytical sample testing across North America. What began in 2011 as a humble 2,500-square-foot operation has become an indispensable resource to cosmetics, nutraceuticals, and pharmaceutical manufacturers navigating complex product formulations and evolving regulatory landscapes.
Every phase of PDA’s journey radiates its founder’s commitment to meeting scientific standards and delivering the market-responsive agility that modern manufacturers demand. Its reputation is not the result of marketing slogans, but of years spent troubleshooting real-world production challenges, turning laboratory analysis into a critical instrument for decision-making where public safety and brand integrity intersect.
Its reputation is hard-earned. Manufacturers and packagers depend on PDA not just to release compliant batches, but to avert costly errors, recalls, and the risk of consumer harm.
“We make sure that formulas are safe, the products are clean, and that there are no pathogens that could harm the end client or ruin the product,” says James Seijas, VP Operations, substantiating its position in the market.
This ethos is reiterated in every technical protocol. The laboratory’s microbiology services include USP <60>, <61> and <62> plate counts, yeast and mold enumeration, and targeted pathogen detection. PDA also specializes in preservative effectiveness testing PCPC (PET) and antimicrobial effectiveness testing USP <51> (AET), which are critical for ensuring product safety.
Beyond routine analysis, it conducts microbial identifications and comprehensive facility assessments, supporting clients with environmental air and surface sampling, aseptic validation on production lines, and raw material evaluations to prevent contamination before it compromises product quality. Stability study programs are also offered, customizing accelerated and real-time conditions with microbiology and analytical testing at designated intervals. Formal OOS (out of specification reports) are available upon request as well.
PDA Laboratories’ analytical division provides advanced solutions like viscosity, assays, organoleptic attributes, pH levels, high-performance liquid chromatography (HPLC), gas chromatography (GC), and specialized testing for regulated impurities such as benzene, and 1,4-dioxane. The analytical lab also specializes in sunscreen actives testing. Recent capital investments have enabled in-house ICP-MS to quantify heavy metals and total organic carbon (TOC) for water analysis, transitioning services once outsourced to rapid, internal processes with stronger data integrity. Method verifications and validations ensure every report is defensible and compliant.
Problem-Solving Beyond the Benchtop
-
We make sure that formulas are safe, the products are clean, and that there are no pathogens that could harm the end client or ruin the product
Problem-Solving Beyond the Benchtop
PDA emphasizes being more than a passive testing provider. The team’s distinction lies in expert consultation and hands-on client support during critical incidents. When a manufacturer faced unresolved micro contamination, PDA’s team went onsite, conducted thorough environmental monitoring, including an assessment of water system integrity, and implemented adequate sanitation and sampling protocols.
This intervention enabled operational recovery and protected the client’s brand reputation.
These services produce more than numbers; they help clients avoid recalls and unsafe product releases, providing essential assurance that has fueled PDA’s growth through positive referrals. PDA ensures that every production line employs proper aseptic techniques, minimizing the risk of contamination and regulatory setback. The company’s responsive reporting—providing preliminary microbiology results within three days and final reports in five to seven days—supports transparency and enables rapid decision-making. The robust Quality Assurance department oversees and electronically transmits reports with extremely low revision rates. This has led to impressive client loyalty, consistent reputation growth, and a thriving referral network for PDA.
Accredited Excellence and Forward Momentum
Regulatory rigor shapes every aspect of PDA’s operation. With ISO 17025 accreditation, FDA registration, Health Canada approval, and a DEA license for controlled substances, PDA’s credentials establish it as a reliable partner for manufacturers whose success depends on accuracy and compliance. Now averaging 20 percent annual growth, PDA is focused on expanding its outreach, visibility, and service capacity.
“We are at a point where we can handle significantly more sample volume,” states Seijas, positioning the facility as ready for increasing market demand without compromising quality.
As oversight tightens and innovation accelerates, PDA remains dedicated to advancing industry standards. Its combination of advanced scientific expertise, regulatory commitment, and hands-on support ensures safe, compliant products for consumers and a more reliable, resilient marketplace for manufacturers.
Protecting Release Timelines through Better Microbiology Testing
A microbiology result that arrives late can hold a release decision in place even when every other quality check is complete. The deeper buying problem is repeat work. Poor sample intake or avoidable report revisions can turn an apparently fast laboratory into a source of delay. Executives evaluating an outside testing partner should look past the test menu and ask how reliably work moves from receipt through reporting under routine production pressure.
Technical fit starts with the methods a laboratory can perform consistently, not the number of services on its website. Environmental monitoring and preservative effectiveness work place different demands on sampling, media selection, incubation controls and interpretation. The laboratory should be able to explain how it handles those differences without introducing unnecessary variation between runs. For buyers in regulated life sciences, the useful distinction is whether procedures produce records that can support internal quality review and external inspection without creating a second round of clarification.
“PDA’s microbiology work includes environmental monitoring using air samplers and contact plates, plus preservative effectiveness and antimicrobial effectiveness testing under USP 51 and PCPC challenge methods.”
Sample movement can be just as consequential as bench work. Environmental monitoring samples may spend time in transit before plating, while routine submissions can lose days through intake backlogs or incomplete handoffs. Buyers should examine how quickly samples enter the laboratory workflow and whether assigned due dates reflect real capacity. Reporting discipline matters too. Preliminary results should arrive when promised and final reports should not routinely require correction. A low revision burden reduces the administrative drag placed on quality staff after the analytical work is finished.
Accreditation provides a reference point, but its practical value depends on how the laboratory applies its quality system between audits. Staffing depth, controlled procedures, training records and workload management offer a clearer view of whether service levels can be sustained as volume changes. An accredited laboratory that accepts more work than its bench can absorb may still miss deadlines. Procurement teams should therefore connect certification status to current staffing capacity rather than treating the certificate itself as a complete proxy for performance.
The strongest selection process tests these factors against the buyer’s own workflow. A provider may have the correct microbiology methods yet still be a poor fit if pickup arrangements or reporting practices create friction for the client. Contract terms and price matter, but they should be considered along with revision frequency and the laboratory’s ability to keep promised dates. The better fit is the laboratory whose technical scope is supported by a service model that remains predictable once routine volume begins.
PDA merits consideration for buyers that need microbiology testing tied closely to dependable sample handling and reporting. Its microbiology work includes environmental monitoring using air samplers and contact plates, plus preservative effectiveness and antimicrobial effectiveness testing under USP 51 and PCPC challenge methods. PDA has also added microbiology technicians and expanded its courier service for established clients within its service radius, allowing collected samples to be brought into the laboratory and plated the same day. Its ISO 17025 recertification gives buyers a quality-system reference point. For teams comparing laboratories on execution rather than test menus alone, this combination is relevant.
...Read more
Microbiology Testing Service Info
Q1
What distinguishes PDA Laboratories among Top Microbiology Testing Services providers?
PDA Laboratories has earned recognition among Top Microbiology Testing Services providers through its combination of regulatory expertise, rapid turnaround times and hands-on scientific support for manufacturers across pharmaceutical, cosmetic and nutraceutical industries. Operating from a large testing facility in New Jersey, the company provides third-party microbiology and analytical testing designed to help clients maintain product safety, regulatory compliance and production continuity. Its reputation has been built through practical problem-solving, responsive reporting and direct technical engagement during contamination events and quality investigations. PDA Laboratories also differentiates itself through its consultative approach that extends beyond routine testing into remediation support and facility assessments.
Q2
How does PDA Laboratories approach microbiology testing and contamination control?
Scientific precision and compliance-focused testing shape the company’s service model. Unlike some Microbiology Testing Services providers that limit support to standard laboratory analysis, PDA Laboratories combines microbiological testing with environmental monitoring, facility evaluations and contamination troubleshooting. Its services include USP <60>, <61> and <62> testing, yeast and mold enumeration, pathogen detection, antimicrobial effectiveness testing and preservative effectiveness testing. The company also conducts environmental air sampling, surface monitoring and aseptic validation designed to identify contamination risks before they affect product quality or regulatory compliance.
Q3
Why is PDA Laboratories relevant to modern manufacturing and quality assurance needs?
Manufacturers across regulated industries face increasing pressure to maintain strict microbiological standards while accelerating production timelines. PDA Laboratories addresses these challenges through Microbiology Testing Services designed to support faster decision-making and stronger quality assurance processes. Its laboratory provides preliminary microbiology reports within approximately three days and final reports within five to seven days for many testing programs, helping clients respond quickly to quality concerns and production requirements. The company’s expertise in contamination prevention, water systems analysis and environmental monitoring also supports evolving regulatory expectations surrounding product safety and manufacturing controls.
Q4
What role does technology and laboratory capability play at PDA Laboratories?
Continuous investment in laboratory infrastructure remains central to PDA Laboratories’ growth strategy. The company has expanded its analytical capabilities through technologies including ICP-MS for heavy metals analysis, TOC testing, HPLC, GC and specialized impurity testing for compounds such as benzene and 1,4-dioxane. Its microbiology facilities include dedicated laboratory space and an ISO Class 5 sterility suite designed to support controlled testing environments. Microbiology Testing Services providers often differentiate themselves through testing range and data reliability, and PDA Laboratories reinforces that distinction through validated methods, electronic barcode systems and accredited quality management practices.
Q5
How does PDA Laboratories support clients during quality investigations and testing challenges?
Direct technical collaboration plays an important role in the company’s client support philosophy. PDA Laboratories works closely with manufacturers during contamination investigations, environmental monitoring reviews and out-of-specification events to identify root causes and corrective actions. Its consulting services include water system evaluations, cleaning validation support, contamination analysis and cGMP-focused remediation guidance. Among Microbiology Testing Services providers, PDA Laboratories stands out for maintaining ongoing communication with clients and providing practical recommendations designed to reduce operational disruption and regulatory risk.
Q6
Why has PDA Laboratories gained recognition in microbiology testing?
Industry recognition for PDA Laboratories reflects its commitment to scientific reliability, regulatory compliance and responsive laboratory support. Life Sciences Review recognized the company as a Top Microbiology Testing Service provider for its ability to combine advanced microbiological analysis with consultative client engagement and operational flexibility. Its ISO 17025 accreditation, FDA registration and Health Canada approval further strengthen its reputation within regulated manufacturing industries. This combination of technical expertise, contamination control support and rapid laboratory reporting continues to reinforce PDA Laboratories’ standing within Microbiology Testing Services.
